Van Dijk PR et al. (1313. van Dijk PR, Ploeg M, Aben KK, Weijerman PC, Karthaus HF, van Berkel JT, et al.: Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival.) |
62 |
375 |
-- |
-- |
-- |
92 |
93.9% (5-year) |
-- |
91.9% (5-year) |
Kassouf W et al. (1515. Kassouf W, Spiess PE, Brown GA, Munsell MF, Grossman HB, Siefker-Radtke A, et al.: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Eur Urol. 2007; 52: 769-74.) |
120 |
1104 |
Yes(77) |
-- |
cT1 21), cT2 (65), cT3b (20), cT4a 11), cT4b (3) |
32 |
88% (5-year) |
84% (5-year) |
84% (5-year) |
Chromecki TF et al. (1717. Chromecki TF, Cha EK, Shariat SF; Bladder Cancer Research Consortium: Stage pT0 after radical cystectomy: are all patients equal? Eur Urol. 2011; 60: 603-4.) |
433 |
5018 |
Yes(41) |
-- |
-- |
46 (TUR-alone) 34 (NAC) |
-- |
-- |
87.2% (TUR-alone) 75.6% (NAC) |
May M et al. (1414. May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, et al.: Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder. BJU Int. 2011; 108: E278-83.) |
132 |
2403 |
-- |
-- |
cTa (5), cTis (9), cT1 (39), cT2 (79) |
53 (mean) |
92% (5-year) |
75% (5-year) |
-- |
Iriarte AL et al. (1111. Loizaga Iriarte A, Senarriaga Ruiz de la Illa N, Lacasa Viscasillas I, Rábade Ferreiro A, Iriarte Soldevilla I, Unda Urzaiz M: Does a pT0 cystectomy specimen imply being tumour-free in the long term?. Actas Urol Esp. 2009; 33: 865-8.) |
20 |
153 |
-- |
-- |
T2 G3 (80%), T2G2 (10%), T1G3 (5%), Tis (5%) |
24 (mean) |
75% |
-- |
65% |
Kaag MG et al. (2323. Kaag MG, Milowsky MI, Dalbagni G, Thompson RH, Katz D, Reuter VE, et al.: Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy. BJU Int. 2011; 108: E272-7.) |
24 |
1905 |
Yes (24) |
-- |
-- |
27 |
-- |
-- |
100% |
Palapattu GS et al. (1010. Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, et al.: Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol. 2006; 175: 1645-9; discussion 1649.) |
59 |
888 |
Yes (8) |
Yes (2) |
cTis (9%), cTa (4%), cT1 (32%), cT2 (52%), cT3 (4%) |
56 |
95% (5-year) |
88% |
90% |
Tilki D et al. (1919. Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, et al.: Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. J Urol. 2010; 184: 888-94. Erratum in: J Urol. 2010; 184: 2218.) |
228 |
4430 |
-- |
-- |
cTa-is (13.6%), cT1 (29.8%), cT2-4a (56.2%) |
48.2 |
93.1% (5-year) |
-- |
89.7% (5-year) |
Volkmer BG et al. (2424. Volkmer BG, Kuefer R, Bartsch G Jr, Straub M, de Petriconi R, Gschwend JE, et al.: Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer. 2005; 104: 2384-91.) |
181 |
900 |
-- |
-- |
Ta/Tis/ T1 (43.1%), T2a / T2b (56.9%) |
120 |
86.5% |
65.9% |
85.2% |
Mateo EM et al. (2525. Mallén Mateo E, Gil Martínez P, Gil Sanz MJ, Sancho Serrano C, Pascual Regueriro D, Rioja Sanz LA: Stage pT0 bladder tumors after radical cystectomy: a review of our series. Actas Urol Esp. 2006; 30: 763-71.) |
43 |
420 |
-- |
-- |
T1 (23.3%), T2 (72%), T3 (4.7%)/G2 (55.8%), G3 (44.2%) |
89.3 |
88.4% |
-- |
83.7% |
Cho KS et al. (2626. Cho KS, Seo JW, Park SY, Cho NH, Choi YD, Yang SC, et al.: The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy. Urol Int. 2008; 81: 394-8.) |
|
197 |
-- |
-- |
|
60 |
84.1% |
-- |
-- |